Research Progress On Cistanche Deserticola Polysaccharides
Nov 18, 2025
Abstract
Cistanche deserticola, a medicinal and edible herb, is highly valued as a tonic in traditional practice. Polysaccharides are among its principal bioactive constituents, with studies demonstrating diverse pharmacological activities, including neuroprotection, immunomodulation, anti‑aging, hepatoprotection, regulation of gut microbiota, and potential antidepressant effects. This review systematically summarizes extraction, separation and purification, structural characterization, and pharmacological activities of C. deserticola polysaccharides. The goal is to provide a theoretical foundation for in‑depth research and commercial development of related products.
Key words
Cistanche deserticola; polysaccharides; extraction; separation and purification; structural features; pharmacological effects; Chinese herbal medicine; review
Cistanche deserticola polysaccharides: Benefits
Supportive Service Of Wecistanche-The largest cistanche exporter in China:
Email:wallence.suen@wecistanche.com
Introduction and Pharmacological Rationale
Cistanche deserticola Y. C. Ma and Cistanche tubulosa (Schenk) Wight refer to the dried, scaly, fleshy stems of the Orobanchaceae plants first recorded in the Shennong Materia Medica. With warm properties and sweet–salty taste, it enters the Kidney and Large Intestine meridians and is traditionally used to tonify kidney yang, nourish essence and blood, and moisten the intestines to relieve constipation. Clinically, it addresses kidney‑yang deficiency, insufficiency of essence and blood, weakness and soreness of the waist and knees, and intestinal dryness with constipation. Its major chemical classes include phenylethanoid glycosides, polysaccharides, iridoids, and lignans. Among these, polysaccharides are a key material basis for efficacy, exhibiting neuroprotective, immunoregulatory, anti‑aging, hepatoprotective, gut‑microbiota‑modulating, and antidepressant activities. Here, we summarize recent domestic and international research on Cistanche polysaccharides, including extraction, separation/purification, structural features, pharmacology, and putative mechanisms, to inform product development and translational applications.
Research Progress on Cistanche Polysaccharides
1.1 Extraction
Polysaccharides are macromolecules linked by glycosidic bonds with complex chemical composition and architecture. Extraction is therefore pivotal, directly affecting yield and structural integrity. Current methods include traditional hot‑water extraction, ultrasound‑assisted extraction, enzyme‑assisted extraction, and newer techniques such as surfactant‑assisted and flash extraction.
1.1.1 Hot‑water extraction
Hot‑water extraction targets water‑soluble polysaccharides but cannot fully disrupt cellular structures, mainly releasing extracellular fractions and often giving lower yield and efficiency. Hence, single‑factor designs combined with response surface methodology (RSM) or orthogonal experiments are commonly used to optimize yield. For Inner Mongolia Cistanche, an optimized process (solid–liquid ratio 1:45 g/mL, 100°C, 130 min) yielded 11.21%. Another orthogonal study on desert Cistanche found a yield of 18.40% at 1:55 g/mL, 75°C, 165 min. Across studies, yield varies with solid–liquid ratio, temperature, and time. Under a fixed 1:50 g/mL and 130–165 min, lower yields were likely due to polysaccharide structural alteration at excessively high temperature.
1.1.2 Ultrasound‑assisted extraction
Ultrasound creates cavitation, generating localized high temperature and pressure that disrupt cell structures and accelerate mass transfer, improving yield and reducing time. However, structural degradation can occur. A single‑factor + orthogonal design suggested optimal conditions of 1:5 g/mL, 60°C, 75 min, with 18.90% yield. A cyclic ultrasound‑enhanced method (1:60 g/mL, 40°C, 1 kW, 10 min) achieved 4.69%-approximately 1.07× the yield of 7 h boiling reflux-highlighting substantial time savings. Industrialization is currently constrained by equipment scale and structure‑preservation challenges.
1.1.3 Enzyme‑assisted extraction
Enzyme‑assisted processes exploit specificity under mild conditions to lower mass‑transfer barriers (cell wall/cytoplasm), promoting release without compromising structure. Cellulase, papain, and pectinase are commonly used, with careful control of pH, temperature, and enzyme activity. Factor analysis showed the influence on yield ranked: enzyme dosage > hydrolysis time > hydrolysis temperature. An optimal process achieved 8.35% yield at 0.20% composite enzyme, 50°C, 1.5 h. Another orthogonal design using ultrasound synergy identified 4.00% composite enzyme, cellulase:pectinase 1:3, 350 W (40 kHz) ultrasound for 20 min, 50°C, pH 6, yielding 5.14%. Enzymatic methods reduce the need for high solid–liquid ratios and energy, but at scale face enzyme consumption, deactivation handling, cost, and tight process‑control requirements.
1.1.4 Other methods
Flash extraction uses high‑speed agitation in a dedicated vessel to rapidly liberate actives, reducing energy and cost. RSM optimization yielded 12.35% at 1:53 g/mL, 5.387×10^3 r/min, 1 min. Surfactant‑assisted extraction (e.g., Tween‑60) enhances solubilization and avoids thermal damage, markedly improving yield over water extraction. Using Tween‑60 with ultrasound at 1:25 g/mL, 60°C, 0.50% Tween‑60, 30 min achieved 8.17%.
1.2 Separation and Purification
Crude polysaccharide extracts contain pigments, proteins, and small molecules, requiring defatting, decolorization, deproteinization, and fractionation. Decolorization commonly employs macroporous adsorption resins or activated carbon; deproteinization uses the Sevag method, enzymatic methods, or enzyme‑Sevag combinations. Using AB‑8 macroporous resin for C. tubulosa crude polysaccharides achieved an average recovery of 81.25%. Among deproteinization strategies, enzymatic deproteinization performed best. Comparing decolorants, AB‑8 outperformed activated carbon. After enzymatic deproteinization plus AB‑8 decolorization, the overall recovery was 88.25% with 84.80% purity. As the resulting material remains a heteropolysaccharide mixture, further fractionation is needed to obtain higher‑purity components. Common columns include DEAE‑650M ion‑exchange, DEAE‑cellulose, AB‑8 macroporous resin, and Sephacryl S‑200 gel filtration, with eluents such as water, graded NaCl, and 60% ethanol, yielding refined fractions for structural and activity studies.
1.3 Structural Features
Structural work focuses on molecular weight, monosaccharide composition and molar ratios, linkage types, and configurations. Techniques include NMR, FT‑IR, HPLC, GC‑MS, and HPGPC. Cistanche polysaccharides are primarily composed of glucose, rhamnose, arabinose, galactose, galacturonic acid, mannose, and xylose in varying ratios, with prevalent α‑pyranose units linked via 1→4 and 1→6 glycosidic bonds (see Table 1 in the source).
Table 1. Chemical Structures of Polysaccharides from Inner Mongolia
| Name | Identification Method | Molecular Weight (kDa) | Monosaccharide Composition | Structural Features | Reference |
|---|---|---|---|---|---|
| CDA-1A | NMR, HPGPC | 10 | Glucose | →6)-α-D-Glcp-(1→; branched | [16] |
| CDA-3B | NMR, HPGPC | 870 | Arabinose, Rhamnose, Galactose, Glucose, Mannose; molar ratio 9.0:2.0:2.0:8.0:2.0 | →4)-α-D-Galp-(1→; →6)-α-D-Glep-(1→; branched arabinogalactan | [16] |
| CDA-0.05 | HPGPC, HPLC, GC, NMR | 7.96 | Glucose, Galactose; molar ratio 96.4:3.6 | →4)-α-D-Glep-(1→; →6)-β-D-Glep-(1→; →6)-β-D-Galp-(1→ | [17] |
| CDP-A | FT–IR | 4.0 × 10³ | Arabinose, Galactose, Glucose, Rhamnose | – | [18] |
| CDP-B | FT–IR | 2.4 × 10³ | Arabinose, Galactose, Glucose, Rhamnose | – | [18] |
| CDP-C | FT–IR | 1.3 × 10³ | Arabinose, Galactose, Glucose, Rhamnose | – | [18] |
| CDCP | HPLC, GC–MS, FT–IR | – | Mainly Glucose, Galactose, Arabinose | Mainly →4)-linked Glc and Galp, with some →3,6)-linked Galp | [19] |
| SPA | HPLC, GC | 8.0 | Rhamnose, Arabinose, Galactose, Glucose; molar ratio 1.8:3.0:1.0:4.1 | →6)-α-D-Galp-(1→; →4)-α-D-Man-(1→; →3)-α-L-Araf-(1→ | [20] |
| CDP-4 | NMR, IR, GC–MS | 14 | Glucose | →6)-α-D-Glcp-(1→ | [21] |
| ACDP-2 | HPLC, NMR, IR, GC–MS | 560 | Arabinose, Rhamnose, Galactose, Glucose; molar ratio 3.5:1.8:1.0:0.9 | →4)-α-D-Galp-(1→; →6)-β-D-Glep-(1→ | [22] |
Commercial R&D Opportunities and New Formulation Ideas
For companies developing evidence‑based herbal therapeutics, functional foods, and premium supplements, Cistanche polysaccharides offer multiple, synergistic product routes. Consider the following development pathways and formulation strategies:
Branded standardized extracts
Offer multi‑grade materials: crude polysaccharides (40–60% total polysaccharides), refined (≥80%), and characterized fractions with defined Mw ranges and monosaccharide profiles.
Dual‑standardization: total polysaccharides plus phenylethanoid glycosides (e.g., echinacoside, acteoside) for platform blends covering immune, cognition, and vitality.
Neuroprotective and healthy aging
Formulation: Cistanche polysaccharides + lion's mane beta‑glucans + phosphatidylserine + magnesium L‑threonate.
Target claims: cognitive support, neuroprotection, mental fatigue reduction. Delivery: sustained‑release tablets or ready‑to‑drink shots.
Immunomodulation and resilience
Formulation: Cistanche polysaccharides + yeast beta‑glucans (1,3/1,6) + vitamin D3 + zinc bisglycinate.
Delivery: sticks/sachets with prebiotic fibers; children's gummies using pectin systems compatible with polysaccharides.
Liver health and metabolic wellness
Formulation: Cistanche polysaccharides + silybin phytosome + NAC + inositol.
Delivery: effervescent tablets to enhance compliance; add lemon‑ginger natural flavors.
Gut microbiota and motility
Formulation: Cistanche polysaccharides + inulin/galacto‑oligosaccharides + Bifidobacterium longum + magnesium citrate (low dose).
Evidence angle: prebiotic synergy; endpoints include stool frequency, SCFA profiles. Delivery: low‑water‑activity powder blends; yogurt‑compatible concentrates.
Mood and stress balance
Formulation: Cistanche polysaccharides + saffron extract (affron‑equivalent) + L‑theanine + magnesium glycinate.
Positioning: "calm focus" for professionals; sugar‑free lozenges or microencapsulated beads.
Sports recovery and vitality
Formulation: Cistanche polysaccharides + taurine + beetroot nitrates + electrolytes.
Messaging: recovery, anti‑fatigue; delivery as isotonic RTD or stick packs.
Process and Quality Recommendations for Scale‑up
Extraction platform
Choose enzyme‑assisted hot water as a base for structure preservation; integrate low‑temperature ultrasound pulses to shorten cycle times while monitoring Mw by HPGPC to avoid depolymerization.
For premium fractions, add gentle surfactant‑assisted steps (food‑grade polysorbates) validated for residuals per pharmacopeial/food standards.
Purification workflow
Pigment removal: AB‑8 as primary, with online UV monitoring to avoid over‑adsorption.
Protein removal: enzymatic route followed by enzyme deactivation and diafiltration to reduce Sevag solvent use.
Analytical specification
Assay panel: total polysaccharides (phenol–sulfuric), monosaccharide profile (HPAEC‑PAD or PMP‑HPLC), Mw distribution (HPGPC with dextran standards), FT‑IR fingerprint, NMR confirmation (1H/13C, HSQC), endotoxin (LAL for parenteral‑grade), residual solvents/surfactants, pesticides, heavy metals, and microbiology.
Stability and formulation tech
Microencapsulation (spray‑dry or fluid‑bed coating) with gum arabic/maltodextrin to protect from humidity and heat.
pH‑responsive coatings for intestinal release in gut‑targeted SKUs.
Granulation for direct compression; optimize water activity to <0.4 for gummies.
Regulatory and Claims Pathways
Dietary supplement/functional food (US/EU): structure–function claims around immune support, gut health, vitality, and healthy aging, supported by in‑house or literature dossiers.
Traditional herbal registrations (select APAC markets): leverage historical use plus modern quality data.
Novel food considerations: document history of safe use for specific fractions and any surfactants/enzymes used.
Suggested Clinical/Preclinical Validation
Immunomodulation: NK‑cell activity, salivary IgA, and URTI incidence in seasonal studies.
Gut health: stool form/frequency, microbiome 16S profiling, SCFAs.
Cognition/fatigue: validated scales (MoCA, POMS‑fatigue), digital cognition tasks.
Liver: ALT/AST, GGT, noninvasive steatosis scores in sub‑healthy populations.
Supply and Sourcing Notes
Botanical identity: C. deserticola vs C. tubulosa-document species, geo‑origin, and voucher specimens.
Sustainability: desert cultivation and traceability; offer carbon/water‑use metrics for ESG reporting.
Takeaway for Product Teams
Cistanche polysaccharides are a versatile, science‑forward backbone for multi‑category portfolios. By pairing optimized, structure‑preserving extraction with clear specifications and smart co‑actives, brands can credibly address cognition, immunity, gut‑liver axis, mood, and vitality-across capsules, gummies, powders, and beverages-while building a defendable quality narrative from raw material to finished dose.
